Show simple item record

dc.contributor.authorJhaveri, K.S.
dc.contributor.authorSchlam, I.
dc.contributor.authorHoltzman, N.G.
dc.contributor.authorPeravali, M.
dc.contributor.authorRichardson, P.K.
dc.contributor.authorDahiya, S.
dc.contributor.authorMalkovska, V.
dc.contributor.authorRapoport, A.P.
dc.date.accessioned2021-02-08T20:13:24Z
dc.date.available2021-02-08T20:13:24Z
dc.date.issued2020-12-07
dc.identifier.urihttp://hdl.handle.net/10713/14541
dc.description.abstracten_US
dc.description.urihttps://doi.org/10.1182/bloodadvances.2020003176en_US
dc.language.isoen_USen_US
dc.publisherAmerican Society of Hematologyen_US
dc.relation.ispartofBlood Advances
dc.subjectautoimmune neuropathyen_US
dc.subjectCAR T cellsen_US
dc.subject.meshComorbidityen_US
dc.subject.meshImmunotherapy, Adoptiveen_US
dc.subject.meshLymphoma, Large B-Cell, Diffuse--therapyen_US
dc.titleSafety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathyen_US
dc.typeArticleen_US
dc.identifier.doi10.1182/bloodadvances.2020003176
dc.identifier.pmid33284942


This item appears in the following Collection(s)

Show simple item record